BUY Ashok Leyland — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))27 Aug 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
8 advisors have active short-term BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · adjacent horizon·28 Aug · today
9 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·28 Aug · today
Market Trading Guide: Ashok Leyland among 2 stock recommendations for Thursday
NewsEt-Markets·26 Aug · yesterday
Ashok Leyland's Diversified Growth Story Intact, Says Nirmal Bang; Raises Target Price Post Q1 Results
NewsNdtv-Profit·17 Aug · 1w ago
Ashok Leyland shares in focus after Q1 results. What are Citi, Nomura analysts saying?
NewsEt-Markets·17 Aug · 2w ago
Buy, Sell Or Hold: Ola Electric, Gillette India, Vedanta, Paytm, Ashok Leyland, Alkem Laboratories — Ask Profit
NewsNdtv-Profit·21 Aug · 6d ago
Ashok Leyland just had a record June quarter. So why did the margin fall a full point?
NewsEt-Markets·18 Aug · 1w ago
Buy, Sell Or Hold: Ashok Leyland, Physicswallah, Meesho, NALCO, Praj Industries — Ask Profit
NewsNdtv-Profit·18 Aug · 1w ago
Ashok Leyland’s demand is on the right track, but margins lag
NewsLivemint·17 Aug · 1w ago
Ashok Leyland Q1: Analysts See More Upside Despite Margin Pressure; Check New Target Prices
NewsNdtv-Profit·17 Aug · 2w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Ashok Leyland
- BUY — Kotak Securities19 Oct 2026 · ~1 year · target ₹180 · Active
- BUY — Sumeet Bagadia, Choice Broking15 Oct 2026 · ~2 weeks · target ₹155 · SL hit
- SELL — Rajesh Satpute7 Oct 2026 · ~3 months · target ₹140 · Active
- BUY — Vishnu Kant Upadhyay, Master Capital Services6 Oct 2026 · ~2 weeks · target ₹175 · SL hit
- BUY — Gaurav Sharma, Globe Capital Market5 Oct 2026 · ~1 year · target ₹200 · Active
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

